Mark Verlander

2.5k citations
14 papers · 1.7k · 3 hit papers · h-index 11

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
  • Genetics top 5%
    • Genetic Associations and Epidemiology

Papers in

    • COVID-19 Clinical Research Studies 7
    • SARS-CoV-2 and COVID-19 Research 1
    • Genetic Associations and Epidemiology 6

Mark Verlander

13 papers receiving 1.6k citations

Mark Verlander's Hit Papers

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 2023 · 125 citations
1250+1+3Years since publication200400600

Peers

Mark Verlander
Comparison fields: 5 of 87
  • Infectious Diseases 849
  • Genetics 504
  • Neurology 87
  • Internal Medicine 18
  • Immunology 103
Replace Valli Ratnam with:
Valli Ratnam United Kingdom
Lucy Howie United Kingdom
Lynn Wren United Kingdom
Mark De Neef United Kingdom
Aayesha Kazi United Kingdom
Norfaizan Ahmad Australia
Jayne Willson United Kingdom
Bernard Hadebe United Kingdom
Louise Wilcox United Kingdom
Amro Katary United Kingdom
Mark Verlander relative to Valli Ratnam United Kingdom Valli Ratnam's profile →
Citations per field
00.5×1.5×
Valli Ratnam · 1×
Citations per year

Countries citing papers authored by Mark Verlander

Since Specialization
Citations

This map shows the geographic impact of Mark Verlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Verlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Verlander more than expected).

Fields of papers citing papers by Mark Verlander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Verlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Verlander. The network helps show where Mark Verlander may publish in the future.

Co-authors

The 5 scholars most cited alongside Mark Verlander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Verlander Line = papers co-authored together Mark Verlander links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Mapping the human genetic architecture of COVID-19
Hit paper breakdown →
2021656
2
Whole-genome sequencing reveals host factors underlying critical COVID-19
Hit paper breakdown →
2022233
3 2021166
4
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Hit paper breakdown →
2023125
5 2022105
6 2022100
7 202172
8 202360
9 202346
10 202143
11 202334
12 20239
13 20248
14 20210

About Mark Verlander

Mark Verlander is a scholar working on Infectious Diseases, Genetics, Occupational Therapy, Nutrition and Dietetics and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Genetic Associations and Epidemiology (6 papers), Speech Recognition and Synthesis (1 paper), Assistive Technology in Communication and Mobility (1 paper), Respiratory Support and Mechanisms (1 paper), Vitamin C and Antioxidants Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (849 citations), Genetics (504 citations), Neurology (87 citations), Internal Medicine (18 citations) and Immunology (103 citations). Mark Verlander has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include James Allan, Imran I. Patel, Bronagh Blackwood, Daniel Francis McAuley and Shondipon Laha. Their work appears in journals such as JAMA, Nature, The Lancet Respiratory Medicine, Critical Care and Intensive Care Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact